Daily Stock Setups

xtremepicks.com: www.Xtremepicks.Com: Xtremepicks Alerts November 16, 2009 : ADPI, FISV, ONXX and NEOG

Posted on: Mon, 16 Nov 2009 10:45:00 EST

Symbols: NEOG, ONXX, FISV, ADPI

Are you looking to increase your ETF knowledge?

American Dental Partners, Inc. (NASDAQ: ADPI | Quote | Chart | News | PowerRating) trading at $11.44 on a volume of 5,593 shares

In a press release out on November 16, American Dental Partners Announces Affiliation With Christie Dental

WAKEFIELD, MA, Nov 16, 2009 -- American Dental Partners, Inc. (NASDAQ: ADPI | Quote | Chart | News | PowerRating) announced today that it has entered into an agreement to acquire certain non-clinical assets of Christie Dental Practice Group, P.L. and Christie Dental Partners, Inc. (collectively, "Christie Dental") and enter into a 40-year service agreement with Christie Dental Practice Group, P.L. The closing of the acquisition is expected to occur on or about December 1, 2009, at which time the service agreement will become effective. Christie Dental will be American Dental Partners' first affiliation with a dental group practice in the state of Florida.

American Dental Partners is one of the nation's leading business partners to dental group practices. The Company is affiliated with 26 dental group practices that have 241 dental facilities with approximately 2,123 operatories located in 18 states.

Fiserv, Inc. (NASDAQ: FISV | Quote | Chart | News | PowerRating) trading at $48.14 per share on trading volume of 39,159 shares.

In a press release out on November 16, Fiserv Ranks First in North America, Fifth Overall, in Chartis' RiskTech100 Report on Global Risk Technology Providers

Momentum in solutions for enterprise financial risk management help drive Fiserv higher in 2009 ranking

BROOKFIELD, Wis., Nov 16, 2009 -- Fiserv, Inc. (NASDAQ: FISV), the leading global provider of financial services technology solutions, announced today that Chartis Research's RiskTech100(TM), a comprehensive annual study of the top global technology firms active in risk management, has ranked Fiserv fifth overall and number one in North America among firms in the RiskTech100 geographic sectors category.

About Fiserv

Fiserv, Inc. (NASDAQ: FISV | Quote | Chart | News | PowerRating) is the leading global provider of information management and electronic commerce systems for the financial services industry, driving innovation that transforms experiences for financial institutions and their customers. Ranked No. 1 on the FinTech 100 survey of top technology partners to the financial services industry, Fiserv celebrates its 25th year in 2009. For more information, visit www.fiserv.com.

Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX | Quote | Chart | News | PowerRating) trading at $28.32 on a volume of 66,309 shares

In a press release out on November 16, Onyx Pharmaceuticals Completes Acquisition of Proteolix, Inc.

EMERYVILLE, Calif., Nov 16, 2009 -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX | Quote | Chart | News | PowerRating) today announced that the company has completed its acquisition of Proteolix, Inc., a privately held biopharmaceutical company focused on discovering and developing novel therapies that target the proteasome for the treatment of hematological malignancies and solid tumors.

About Onyx Pharmaceuticals, Inc.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer. The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developing and marketing Nexavar(R) (sorafenib) tablets, a small molecule drug that is currently approved for the treatment of liver cancer and advanced kidney cancer. Additionally, Nexavar is being investigated in several ongoing trials in a variety of tumor types. Beyond Nexavar, Onyx has established a development pipeline of anticancer compounds at various stages of clinical testing, including carfilzomib, a next-generation proteasome inhibitor, that is currently being evaluated in multiple clinical trials for the treatment of patients with relapsed or relapsed/refractory multiple myeloma and solid tumors, and ONX 0801, a targeted alpha-folate inhibitor, currently in Phase 1 testing. For more information about Onyx, visit the company's website at www.onyx-pharm.com.

Neogen Corporation (Nasdaq: NEOG | Quote | Chart | News | PowerRating) trading at $32.34 on a volume of 5,604 shares

In a press release out on November 16, Neogen Announces 3 for-2 Stock Split

LANSING, Mich., Nov 16, 2009 -- Neogen Corporation (Nasdaq: NEOG | Quote | Chart | News | PowerRating) today announced that its Board of Directors has approved a 3-for-2 stock split. With the split, shareholders of record on Nov. 30, 2009, will receive one additional share of stock for each two shares held.

Neogen Corporation develops and markets products dedicated to food and animal safety. The Company's Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides.

Xtremepicks.com profiles early stage microcap and growth stocks that provide innovative products or services resulting in potentially "hyper-growth" opportunities. Often, these companies have yet to be recognized by Wall Street and the undiscovered nature of Xtremepicks.com's profile companies provide our members the opportunity to learn about these companies at their development stage, and more importantly before they possibly "turn the corner" and get exposed to a much larger investing audience.

Xtremepicks.com (www.Xtremepicks.com) has prepared all material herein based upon information believed to be reliable. The information contained herein is not guaranteed by Xtremepicks.com to be accurate, and should not be considered to be all-inclusive. Xtremepicks.com is a leading information resource for evaluating investment opportunities in small and microcap stocks. We focus on a limited number of companies in order to provide comprehensive coverage, including unique investment related features not available anywhere else on the Internet. To feature a company or to get more information, please visit us at www.Xtremepicks.com or email us at info@Xtremepicks.com Xtremepicks.coms affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event of a rise in value. Xtremepicks.com will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

To view full disclaimers, go to http://www.Xtremepicks.com/disclaimer.htm

CONTACT: Xtremepicks.com
e-mail: Info@xtremepicks.com
WWW: http://www.Xtremepicks.com

((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

For full details on Neogen Corp (NEOG) NEOG. Neogen Corp (NEOG) has Short Term PowerRatings at TradingMarkets. Details on Neogen Corp (NEOG) Short Term PowerRatings is available at This Link.

For full details on Onyx Pharmaceuticals Inc (ONXX) ONXX. Onyx Pharmaceuticals Inc (ONXX) has Short Term PowerRatings at TradingMarkets. Details on Onyx Pharmaceuticals Inc (ONXX) Short Term PowerRatings is available at This Link.

For full details on Fiserv Inc (FISV) FISV. Fiserv Inc (FISV) has Short Term PowerRatings at TradingMarkets. Details on Fiserv Inc (FISV) Short Term PowerRatings is available at This Link.

For full details on American Dental Partners (ADPI) ADPI. American Dental Partners (ADPI) has Short Term PowerRatings at TradingMarkets. Details on American Dental Partners (ADPI) Short Term PowerRatings is available at This Link.

More News: Market Updates | Stock Alerts | All Trading News

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.